FilingSEC EDGAR8-K
PMV Pharmaceuticals Appoints Dr. Matt Eckler to Board of Directors
· SEC accepted
StageBoard Appointment
Filing content
PMV Pharmaceuticals appointed healthcare investment expert Dr. Matt Eckler to its Board of Directors as it prepares for a 2027 Q1 NDA submission for rezatapopt.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…